De Novo Onset of Parkinson's Disease After Antidepressant Treatment With Citalopram

References

• 1 Kapur S, Remington G. Serotonin-dopamine interaction and its relevance to schizophrenia.  Am. J. Psychiatry. 1996;  153 4
• 2 Caley C F. Extrapyramidal reactions and the selective serotonin-reuptake inhibitors.  Ann. Pharmacother.. 1997;  31(12) 1481-1489
• 3 Stahl St. Not so selective serotonin reuptake inhibitors.  J. Clin. Psychiatry. 1998;  59 7
• 4 Muldoon C. The safety and tolerability of citalopram. International clinical psychopharmacology 1996 11, Supplement 1
• 5 Hyttel J. Citalopram - pharmacological profile of a specific serotonin uptake inhibitor with antidepressant activity.  Prog. Neuropsychopharmacol. Biol. Psychiatry. 1982;  6(3) 277-295
• 6 Korsgaard S, Noring U, Polvsen U J, Gerlach J. Effects of citalopram, a specific serotonin uptake inhibitor, in tardive dyskinesia and parkinsonism.  Clinical Neuropharmacology. 1986;  1 52-57
• 7 Bernheimer H, Birkheimer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington: clinical, morphological and neurochemical correlations.  J. Neurol. Sci.. 1973;  20 415-455
• 8 Melamed E, Hefti F, Wurtman R F. Compensatory mechanisms in the nigrostriatal dopaminergic system in Parkinson's disease: studies in an animal model.  Isr. J. Med. Sci.. 1982;  18 159-163
• 9 Amann B, Erfurth A, Back T, Grunze H. Severe treatment-resistant depression preceding Parkinson's disease.  Psychiat. Prax.. 1999;  26 45-47